Pikralida Sp. z o.o.
- Address
- Ul. Uniwersytetu Poznanskiego 10
Sponsor Overview
Specializations
Healthy volunteer pharmacokinetics
Research activity is centered on pharmacokinetic evaluation in healthy subjects, with interest in how an orally administered compound is handled by the body over time.
- Oral drug absorption
- Single-dose exposure
- Multiple-dose exposure
The sponsor’s clinical interest is focused on early human assessment of PKL-021 in a controlled volunteer setting.
Absorption and systemic exposure
The trial activity reflects a focus on measuring systemic exposure after oral administration, with attention to how the compound is distributed and cleared in the body.
- Plasma concentration profiling
- Bioavailability assessment
- Exposure-response characterization
This area supports clinical understanding of the compound’s behavior in human pharmacology.
Early clinical development
Clinical research interest includes foundational human studies that inform the development of an investigational medicinal product before broader therapeutic use.
- Safety monitoring in volunteers
- Tolerability assessment
- Oral formulation performance
The sponsor’s active trial portfolio is concentrated in a single-site clinical research setting in Poznan, Poland.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Pharmacokinetic Evaluation of Oral PKL-021 in Single and Multiple Doses in Healthy Volunteers | Czechia | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
1 centre- Address
- Prazska 1486/18c, Hostivar, 102 00 Prague
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Pikralida Sp. z o.o..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

